- Home
- ZNB vs CRIS Comparison
ZNB vs CRIS Comparison
Compare ZNB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNB | CRIS |
|---|---|---|
| Founded | 2002 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0M | 976.1K |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ZNB | CRIS |
|---|---|---|
| Price | $0.49 | $0.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $42.67 |
| AVG Volume (30 Days) | 223.0K | ★ 502.4K |
| Earning Date | 10-19-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.10 | $0.33 |
| 52 Week High | $9.78 | $3,180.00 |
Technical Indicators
Market Signals| Indicator | ZNB | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 22.21 | 23.27 |
| Support Level | $0.17 | $0.33 |
| Resistance Level | $1.90 | $5.50 |
| Average True Range (ATR) | 0.11 | 0.07 |
| MACD | -0.01 | 0.52 |
| Stochastic Oscillator | 4.80 | 59.80 |
Price Performance
Historical ComparisonAbout ZNB Zeta Network Group Class A Ordinary Shares
Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.